Skip to main content

Psoriasis clinical trials at UCSF
4 in progress, 3 open to new patients

  • Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that the new dosing strategy will result in faster improvement of psoriasis.

    San Francisco, California

  • Immunologic Response to Secukinumab in Plaque Psoriasis

    open to eligible people ages 18 years and up

    This is a single-arm, open-label study, which will examine the effect of secukinumab on the immunologic and genetic environment within psoriatic lesions.

    San Francisco, California

  • Single Cell Genomics of Psoriatic Skin

    open to eligible people ages 18 years and up

    The purpose of this study is to understand how genetics play a role in psoriasis. Specifically, a genetic allele HLA-Cw6 is known to be assoicated with psoriasis, and this study aims to find out how it affects genetic and protein expression in patients with psoriasis, compared to healthy people, at a single-cell level using a novel flow cytometry and RNA-sequencing protocol.

    San Francisco, California

  • A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab (CNTO 1959) in the treatment of participants with moderate to severe plaque-type psoriasis.

    San Francisco, California and other locations